Novo Nordisk A/s

(CPSE) NOVO B

Current Price$0.00

Market CapN/A

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

Novo Nordisk A/s Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$309.06K

Net Income (TTM)

$102.43K

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

NOVO B News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novo Nordisk A/s

Industry

Pharmaceuticals

Sector

Health Care

Employees

68,794

CEO

Maziar Mike Doustdar

Website

www.novonordisk.com

NOVO B Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Novo Nordisk A/s Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$79.14K

+0.9%

Gross Profit

$64.00K

+0.9%

Gross Margin

80.86%

+1.0%

Market Cap

N/A

Market Cap/Employee

$21.01

+0.6%

Employees

68,794

+0.9%

Net Income

$26.89K

+1.0%

EBITDA

$37.47K

+0.9%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$26.46K

+1.7%

Accounts Receivable

$70.86K

+1.0%

Inventory

$49.62K

+1.2%

Long Term Debt

$118.94K

+1.3%

Short Term Debt

$12.02K

+0.9%

Return on Assets

20.31%

+0.8%

Return on Invested Capital

56.27%

+0.9%

Free Cash Flow

$10.81K

+2.8%

Operating Cash Flow

$7.62K

+0.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7242.19+0.00%

^DJIDJI

^DJIDJI$49593.36-0.00%

^IXICNASDAQ

^IXICNASDAQ$25153.01+0.01%

BTCBitcoin

BTCBitcoin$78555.00+0.03%

AAPLAAPL

AAPLAAPL$280.86+0.04%

AMZNAMZN

AMZNAMZN$269.57+0.02%

GOOGGOOG

GOOGGOOG$381.60-0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RBLXRoblox

RBLXRoblox$45.13-0.18%

Questions About NOVO B

What is the current price of Novo Nordisk A/s?

Novo Nordisk A/s is trading at N/A per share.

What is the 52-week range for Novo Nordisk A/s?

Over the past 52 weeks, Novo Nordisk A/s has traded between N/A and N/A.

How much debt does Novo Nordisk A/s have?

As of the most recent reporting period, Novo Nordisk A/s reported total debt of $130.96B.

How much cash does Novo Nordisk A/s have on hand?

Novo Nordisk A/s reported $26.46B in cash and cash equivalents in its most recent financial results.

What is Novo Nordisk A/s’s dividend yield?

Novo Nordisk A/s does not currently have a dividend yield.

Novo Nordisk A/s

Novo Nordisk A/s Financials at a Glance

NOVO B News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Novo Nordisk A/s

NOVO B Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Novo Nordisk A/s Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NOVO B

What is the current price of Novo Nordisk A/s?

What is the 52-week range for Novo Nordisk A/s?

How much debt does Novo Nordisk A/s have?

How much cash does Novo Nordisk A/s have on hand?

What is Novo Nordisk A/s’s dividend yield?

Premium Investing Services